FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2497406922> ?p ?o ?g. }

• W2497406922 abstract "For around a third of people with a diagnosis of schizophrenia, the condition proves to respond poorly to treatment with many typical and atypical antipsychotics. This is commonly referred to as treatment-resistant schizophrenia. Clozapine is the only antipsychotic with convincing efficacy for people whose symptoms are considered treatment-resistant to antipsychotic medication. However, 30–40 % of such conditions will have an insufficient response to the drug. Cognitive behavioural therapy has been shown to be an effective treatment for schizophrenia when delivered in combination with antipsychotic medication, with several meta-analyses showing robust support for this approach. However, the evidence for the effectiveness of cognitive behavioural therapy for people with a schizophrenia diagnosis whose symptoms are treatment-resistant to antipsychotic medication is limited. There is a clinical and economic need to evaluate treatments to improve outcomes for people with such conditions. A parallel group, prospective randomised, open, blinded evaluation of outcomes design will be used to compare a standardised cognitive behavioural therapy intervention added to treatment as usual versus treatment as usual alone (the comparator group) for individuals with a diagnosis of schizophrenia for whom an adequate trial of clozapine has either not been possible due to tolerability problems or was not associated with a sufficient therapeutic response. The trial will be conducted across five sites in the United Kingdom. The recruitment target of 485 was achieved, with a final recruitment total of 487. This trial is the largest definitive, pragmatic clinical and cost-effectiveness trial of cognitive behavioural therapy for people with schizophrenia whose symptoms have failed to show an adequate response to clozapine treatment. Using a prognostic risk model, baseline information will be used to explore whether there are identifiable subgroups for which the treatment effect is greatest. Current Controlled Trials ISRCTN99672552 . Registered 29th November 2012." @default.
• W2497406922 created "2016-08-23" @default.
• W2497406922 creator A5004165162 @default.
• W2497406922 creator A5005098821 @default.
• W2497406922 creator A5009791745 @default.
• W2497406922 creator A5017525685 @default.
• W2497406922 creator A5024552084 @default.
• W2497406922 creator A5025816641 @default.
• W2497406922 creator A5030418835 @default.
• W2497406922 creator A5034159571 @default.
• W2497406922 creator A5054014410 @default.
• W2497406922 creator A5061749118 @default.
• W2497406922 creator A5062635411 @default.
• W2497406922 creator A5066036106 @default.
• W2497406922 creator A5072164974 @default.
• W2497406922 creator A5074731029 @default.
• W2497406922 creator A5074884532 @default.
• W2497406922 creator A5076639790 @default.
• W2497406922 creator A5082417373 @default.
• W2497406922 creator A5088701123 @default.
• W2497406922 date "2016-08-05" @default.
• W2497406922 modified "2023-09-27" @default.
• W2497406922 title "Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trial" @default.
• W2497406922 cites W164302377 @default.
• W2497406922 cites W1963935327 @default.
• W2497406922 cites W1964438525 @default.
• W2497406922 cites W1976741101 @default.
• W2497406922 cites W1978345775 @default.
• W2497406922 cites W1989904540 @default.
• W2497406922 cites W1992857340 @default.
• W2497406922 cites W1993211119 @default.
• W2497406922 cites W1995380902 @default.
• W2497406922 cites W2009969771 @default.
• W2497406922 cites W2018317330 @default.
• W2497406922 cites W2041224506 @default.
• W2497406922 cites W2049907076 @default.
• W2497406922 cites W2055461575 @default.
• W2497406922 cites W2061304590 @default.
• W2497406922 cites W2061410297 @default.
• W2497406922 cites W2066357241 @default.
• W2497406922 cites W2079389497 @default.
• W2497406922 cites W2092884989 @default.
• W2497406922 cites W2096987981 @default.
• W2497406922 cites W2106203584 @default.
• W2497406922 cites W2112579263 @default.
• W2497406922 cites W2115041319 @default.
• W2497406922 cites W2115115146 @default.
• W2497406922 cites W2117698532 @default.
• W2497406922 cites W2120028475 @default.
• W2497406922 cites W2123785744 @default.
• W2497406922 cites W2125885438 @default.
• W2497406922 cites W2128269126 @default.
• W2497406922 cites W2130363382 @default.
• W2497406922 cites W2131115009 @default.
• W2497406922 cites W2131564374 @default.
• W2497406922 cites W2135077565 @default.
• W2497406922 cites W2140526915 @default.
• W2497406922 cites W2141225113 @default.
• W2497406922 cites W2144585543 @default.
• W2497406922 cites W2149361395 @default.
• W2497406922 cites W2153356230 @default.
• W2497406922 cites W2155434048 @default.
• W2497406922 cites W2157447397 @default.
• W2497406922 cites W2162176367 @default.
• W2497406922 cites W2162176680 @default.
• W2497406922 cites W2164040597 @default.
• W2497406922 cites W2168690096 @default.
• W2497406922 cites W2175466887 @default.
• W2497406922 cites W2313236961 @default.
• W2497406922 cites W2914389016 @default.
• W2497406922 cites W4294113123 @default.
• W2497406922 cites W4320800471 @default.
• W2497406922 doi "https://doi.org/10.1186/s12888-016-0983-6" @default.
• W2497406922 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4974812" @default.
• W2497406922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27496180" @default.
• W2497406922 hasPublicationYear "2016" @default.
• W2497406922 type Work @default.
• W2497406922 sameAs 2497406922 @default.
• W2497406922 citedByCount "13" @default.
• W2497406922 countsByYear W24974069222017 @default.
• W2497406922 countsByYear W24974069222018 @default.
• W2497406922 countsByYear W24974069222019 @default.
• W2497406922 countsByYear W24974069222020 @default.
• W2497406922 countsByYear W24974069222021 @default.
• W2497406922 crossrefType "journal-article" @default.
• W2497406922 hasAuthorship W2497406922A5004165162 @default.
• W2497406922 hasAuthorship W2497406922A5005098821 @default.
• W2497406922 hasAuthorship W2497406922A5009791745 @default.
• W2497406922 hasAuthorship W2497406922A5017525685 @default.
• W2497406922 hasAuthorship W2497406922A5024552084 @default.
• W2497406922 hasAuthorship W2497406922A5025816641 @default.
• W2497406922 hasAuthorship W2497406922A5030418835 @default.
• W2497406922 hasAuthorship W2497406922A5034159571 @default.
• W2497406922 hasAuthorship W2497406922A5054014410 @default.
• W2497406922 hasAuthorship W2497406922A5061749118 @default.
• W2497406922 hasAuthorship W2497406922A5062635411 @default.
• W2497406922 hasAuthorship W2497406922A5066036106 @default.
• W2497406922 hasAuthorship W2497406922A5072164974 @default.
• W2497406922 hasAuthorship W2497406922A5074731029 @default.
• W2497406922 hasAuthorship W2497406922A5074884532 @default.

• next